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Abstract
Purpose: It is known that both human conjunctival fibroblasts (HCF) and corneal epithelial (HCE) cells contribute to
the inflammatory process in the ocular surface by releasing inflammatory cytokines. In addition, nitric oxide (NO)
has an important role in inflammatory responses in the ocular surface. In the present study, we aimed to
characterize the capacity of these cells to release nitric oxide in response to cytokines and Lipopolysaccharide (LPS),
and show that Alpha-linoleic acid (ALA) inhibits these responses.
Methods: HCF, HCE cells, peripheral blood mononuclear cells (PBMCs) and co-culture of HCF and PBMC were
treated with different combinations of inflammatory inducers, including interleukin)IL- (6, tumor necrosis factors
(TNF)-α, interferon (IFN)- γ and IL-1β and LPS. Nitrite levels were measured in cell supernatants with and without
ALA by the Griess reaction test at 24, 48 and 72 h respectively. Expression of nitric oxide synthase 2 (NOS-2) was
evaluated by real-time PCR.
Results: All cytokine combinations had an inducible effect on nitrite secretion in HCF, PBMC and co-cultured PBMC
and HCF, but not in HCE cells. Treatment with a combination of IL-6, LPS, TNF-α, IFN- γ and IL-1β induced the
highest nitrite secretion (2.91 fold, P < 0.01) as compared to cells incubated in medium alone. nitrite secretion was
reduced by 38.9 % (P < 0.05) after treatment with ALA alone. Co-culturing PBMC with HCF with and without ALA
treatment demonstrated similar results in nitrite level as,compared to PBMC alone. In addition, ALA significantly
decreased NOS-2 expression in HCF by 48.9 % (P < 0. 001) after 72 h.
Conclusions: The decrease in nitrite release and inhibition of NOS-2 expression indicate that ALA may have an
anti-inflammatory effect both on HCF and on peripheral immune cells. This indicates that ALA may serve as a
potent anti-inflammatory agent in ocular surface inflammation.
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Introduction
Polyunsaturated fatty acids (PUFAs) including alpha
-linolenic acid (ALA), are the precursors of eicosanoid
molecules, which are key players in inflammatory pro-
cesses [1, 2]. PUFA-18:3 (n-3) derived eicosanoids have
anti-inflammatory properties, while PUFA-18:2 (n-6)
derived eicosanoids are considered to have pro-
inflammatory characteristics [2–4].
The first evidence to examine the important that dietary
intake of omega-3 PUFA plays and its effects on inflam-
mation was derived from epidemiological observations of
low incidence of myocardial infarction [5], rheumatoid
arthritis and cardiovascular disease [6] in populations
supplemented with n-3 PUFA. In addition, studies have
confirmed that there is a relationship between oral sup-
plementation of PUFAs and improvement in dry eye
disease as well as in contact lens intolerance [7, 8]. A re-
cent study found that topical ALA decreased the clinical
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signs of dry eye syndrome in a mouse model of the dis-
ease [9]. We have recently demonstrated that ALA has
potent anti-inflammatory effects on human corneal epi-
thelial (HCE) cells stimulated by Lipopolysaccharide
(LPS) or polyriboinosinic:polyribocytidylic acids (poly
I:C) in-vitro. Both protein and mRNA levels of several
pro-inflammatory cytokines decreased following treat-
ment with ALA [10].
Nitric oxide (NO) is a free radical which plays an im-
portant role in vasodilatation of smooth muscle,
neurotransmission, and cytotoxicity [11]. In addition,
inducible NO has an important role in immune and in-
flammatory responses [12], contributing to the acute
immune response by two distinct pathways. The first
pathway is direct, in which NO has a toxic effect
against infectious organisms as part of the innate im-
mune system [13]. The second is indirect, in which NO
is capable of inducing or regulating the function of im-
mune cells as part of the specific immune system [14,
15]. Previous studies related to NO’s effect in the ocu-
lar surface suggested several roles for NO, such as cell
damage during infection [16, 17], pathogenesis of
endotoxin-induced uveitis [18], inhibiting neovascular-
ization [19], producing corneal edema [20], and indu-
cing allergic reactions [21].
There are three isoforms of the Nitric oxide syn-
thase (NOS); each has a particular function. The first
two are calcium-dependent endothelial (NOS-3) and
neuronal (NOS-1) enzymes, which produce low
levels of NO as a cell signaling molecule in resting
cells [22]. The third is the inducible calcium inde-
pendent isoform (NOS-2) which is responsible for
the release of NO during inflammation, and is up-
regulated by a variety of extracellular stimuli such as
interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α),
and LPS [23, 24].
Inflammatory ocular surface diseases involve the con-
junctival fibroblasts and immune cells at the ocular sur-
face. These cells were shown to release NO at basal
conditions [25], but to the best of our knowledge, these
cells were not tested for their capacity to respond to im-
munomodulators. Therefore we have characterized the
capacity of HCF and HCE cells to release nitrite at basal
conditions and also after activation with immunomodu-
lators. In addition, we investigated the anti-inflammatory
effects of ALA on HCF.
Methods
The Hadassah Medical Center Institutional Review
Board (IRB) approval was obtained for this study (IRB
protocol number and version: EFA-EFE-IV-01), and all
of the study procedures were carried out in accordance
with the IRB guidelines. This study followed the tenets
of the Helsinki Declaration.
Human Corneal Epithelial (HCE) cells and Human
Conjunctival Fibroblasts (HCF)
HCE cells were obtained from human corneoscleral rim
explants, taken from three different human donors, pro-
vided by the Department of Ophthalmology at the
Hadassah Medical Center, using a previously described
method [26]. HCE cells were cultured in supplemented
hormonal epithelial medium (SHEM) [27]. HCE cells
were incubated at 37 °C under 95 % humidity and 5 %
CO2. The culture medium was replaced every other day.
Cultures were kept for 10 to 14 days until a density of
90 % confluence was observed. At this time, cells were
passaged and seeded onto 6-well plates at a density of
2.0 x105 cells/well. Cells were observed by phase-
contrast microscopy to ensure uniformity of morph-
ology. The purity of HCE cultures was confirmed by
staining for cytokeratin- 19with the indirect immunoper-
oxidase procedure with a monoclonal antibody to human
cytokeratin-19 (Abcam, UK). Second generation cells were
used in all experiments.
Human conjunctiva explant cultures were established
using specimens obtained at the time of strabismus sur-
gery. The human conjunctival explants were taken from
four different human donors. The isolation and culture
of cell explants were performed within 1–3 h after the
strabismus surgery. HCF cells were cultured as previ-
ously described [28]. In brief, HCF cells were cultured in
fibroblast medium, which contained Dulbecco’s modified
Eagle medium (DMEM) with nutrient mixture F12
(Gibco), supplemented with 4 mM glutamine, 10 % fetal
calf serum (FCS), 100 U of penicillin, and 100 μg of
streptomycin/ml. HCF were incubated at 37 °C under
95 % humidity and 5 % CO2. The medium was replaced
every 2–3 days. Cultures were kept for 10 to 14 days
until a density of 90 % confluence was observed.
Culture of human peripheral blood mononuclear cells
(PBMCs)
Human PBMCs were isolated from buffy coats provided
by the blood bank of the Hadassah Medical Center. The
blood donors were four healthy males aged between 25
and 45. PBMCs were isolated as previously described
[29, 30]. Briefly, whole blood was transferred via tubes
covered with anticoagulant and mixed with RPMI in a
1:1 ratio. Ficoll was added to a new tube in a 1:1 ratio to
the whole blood (originally before the blood/RPMI mix-
ture), with an additional 3 mL of Ficoll. Blood/RPMI
mixture was added to the Ficoll in a slow stream to
maintain the gradient, and the tube was centrifuged for
30 min at 1600 rpm. The top layer (plasma) was aspi-
rated and the buffy coat (the interface) was removed
with a tube and mixed with RPMI to comprise a 50 ml
total mixture. The top layer was aspirated and the cells
were covered once again with new RPMI (50 ml) and
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centrifuged for another 10 min. The top layer was aspi-
rated, and 1.0 ml of monocyte isolation buffer was
added.
Fatty acids
Alpha linolenic acid (ALA; 18:3 n-3) was obtained as >99 %
pure sodium salt (Nuchek Prep Inc, Elysian, Minnesota,
USA). ALA was dissolved in distilled water in a nitrogen
chamber, filtered through a 0.2-μm-pore-size filter, divided
into aliquots, and sealed under nitrogen in opaque eppen-
dorf tubes. ALA was stored at −80 °C for no longer than
90 days before use. Fatty acids were conjugated with bovine
serum albumin (BSA, Fraction V, Mercury, Israel) at a 5:1
molar ratio before treatment. In order to avoid oxidative
effects, the fatty acids were defrosted once and were not
reused again.
Experimental designs
HCF and HCE cells were seeded into 6 wells plates for
72 h (density of 1.2x105 cells/well) in 2.0 ml of medium.
To induce inflammation, HCF and HCE cells were
treated with different mixtures of pro-inflammatory cy-
tokines and Lipopolysaccharide (1 to 100 ng/ml) combi-
nations (Table 1). Culture medium was sampled at 24,
48 and 72 h, and nitrite accumulation was measured at
each time period. HCF and HCE cells treated with com-
binations 1 to 5 (Table 1) were lysed at 72 h to extract
RNA for RT-PCR analysis.
Production of nitric oxide may promote inflammation
in mononuclear cells as previously described [31]. Our
preliminary results showed that PBMC released high
amounts of nitrite after treatment with LPS only. Co-
cultured human PBMCs (density of 2.0 x 105 cells/well)
with HCF in 2.0 ml of medium were treated with LPS
only (1 to 1000 ng/ml LPS). In addition, co-cultured
PBMC with HCF were stimulated by LPS at similar con-
ditions to those of PBMC and HCF alone. Culture
medium was sampled at 24, 48 and 72 h. Nitrite accu-
mulation was measured at each time period.
HCF, HCE cells, and human PBMCs were pre-incubated
for two hours with 200 μM ALA before treatment with
the inflammatory stimulus [32].
Griess reaction
NO is unstable in culture medium. Nitrite accumulation,
an indicator of NO synthesis, was measured in the cul-
ture medium by Griess reaction at 24, 48 and 72 h [33].
Briefly, 80 μL of cell culture medium was mixed with
20 μL of Griess reagent [equal volumes of 1 % (w/v) sulf-
anilamide in 5 % (v/v) phosphoric acid and 0.1 % (w/v)
naphthylethylenediamine-HCl] and incubated at room
temperature for 10 min. The absorbance at 550 nm was
then measured using a microplate reader. Fresh culture
medium was used as a blank in all experiments. The
amount of nitrite in the test samples was calculated from
a sodium nitrite standard curve.
RNA isolation
Following treatment, total RNA was extracted from the
HCF and HCE cell samples with RNAqueous Kit
(Ambion, USA) following the manufacturer’s instruc-
tions. Quantification of total RNA was performed in a
NanoDrop spectrophotometer (ND-1000, USA). RNAs
were stored at −80 °C until further utilization.
cDNA synthesis
cDNA was synthesized from purified and concentrated
0.5 μg RNA from each sample using a High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems,
ABI, USA). A 20 μl total reaction volume was made with
10 μl RNA, 2 μl 10X RT buffer, 0.8 μl dNTP Mix
(100 mM), 2.0 μl 10X RT random hexamer primers,
1.0 μl MultiScribe™ reverse transcriptase, 1 μl RNase in-
hibitor and 3.2 μl nuclease-free water. Synthesis was car-
ried out in an ABI 7900 Thermo cycler (ABI, USA) and
RT-PCR reaction conditions were comprised of: 25 °C
for 10 min, 37 °C for 120 min, and 85 °C for 5 mins.
cDNA samples were stored at −20 °C until use.
Real-time polymerase chain reaction
Real-time polymerase chain reaction (Real-time PCR)
was performed using TaqMan ® Gene Expression Assays
(ABI, USA) in the ABI Prism 7900HT Sequence Detec-
tion System (ABI, USA) as previously described [34, 35].
Negative controls were included to evaluate DNA con-
tamination of isolated RNA and reagents.
Real-time PCR assays for iNOS probe (ABI, USA)
were performed. An amount of 1 μL cDNA was loaded
in each reaction, to a total volume of 20 μl of reaction
mixture, and assays were performed in triplicates.
The fold change in gene expression was normalized to
the expression of the endogenous gene hypoxanthine
phosphoribosyltransferase 1 (HPRT1; ABI, USA). Quan-
titative analysis was performed using the comparative
(ΔΔCT) method [34, 35] The results were analyzed by
DataAssist™ SoftwareV 2.0 (ABI, USA).
Table 1 The pro-inflammatory combinations added to cultures
of HCE cells and HCF
Combination 1 LPS(10 ng/ml) + IL-6+ YNFα + IFNγ + IL-1β
Combination 2 LPS(1 ng/ml) + IL-6 + TNFα
Combination 3 LPS(10 ng/ml) + IL-6 + TNFα
Combination 4 LPS(10 ng/ml) + TNFα + IFNγ
Combination 5 LPS(100 ng/ml) + IL-6 + TNFα + IFNγ + IL-1β
The pro-inflammatory cytokines include: IFN- γ, TNF-α, IL-1β and IL-6. Each
cytokines’ concentration was kept constant throughout all combinations, and
was 100 ng/ml
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Statistical analysis
All tests were carried out on three independent cell cul-
tures, and performed in triplicate for each of the treat-
ments. In the experiments of the effect of ALA on
nitrite secretion in HCF and effect of ALA on NOS-2
mRNA expression tests, we carried out the tests on four
independent cell cultures, and performed triplicates for
each of the treatments.
Statistical analysis and multiple comparisons were per-
formed by one-way ANOVA using the InStat software
version 3.0 (InStat software Inc., Graphpad, San Diego,
CA). The differences in mean values among treatment
groups were determined by ANOVA adjusted for mul-
tiple comparison by the Tukey test, ANOVA adjusted
for multiple comparison by the Student-Newman-Keuls
test, and ANOVA with multiple comparison by the Bon-
ferroni t-test.
Results
Nitrite levels induction in HCF and HCE cells
In order to induce nitrite synthesis in HCF and HCE
cells, we used 5 different combinations of cytokines and
LPS as depicted in Table 1. Primary cultures of HCF
from three individual corneas were incubated with the 5
different combinations of stimulators (n = 3). Of these
combinations, combinations #1 and #5 were found to be
the optimal combinations that caused the highest nitrite
secretion after 24–72 h (Fig. 1).
We observed 20.93 ± 3.1 and 22.82 ± 2.65 fold higher
levels of nitrite in combination #1 and #5 respectively
(P < 0.01) after 48 h of stimulation. After 72 h of stimu-
lation we observed 34.81 ± 5.0 and 33.9 ± 7.17 fold
higher levels of nitrite in combination #1 and #5 respect-
ively (P < 0.01). Therefore, we chose to use treatment
with combination #1 for 72 h in HCF for further experi-
ments, as it produced the highest levels of nitrite.
The HCE cells that were treated with the same combi-
nations of cytokines and LPS showed very low amounts
of nitrite accumulation after 24 to 72 h.
Effect of ALA on Nitrite secretion in HCF and PBMCs
We wished to determine if there was a beneficial effect if
ALA was added to cells in an inflammatory environ-
ment. Therefore, we incubated HCF with ALA for 2 h
and then exposed the cells to 10 ng/ml LPS and cyto-
kines as was described in combination # 1. Nitrites were
evaluated in supernatants after 72 h (n = 3).
We compared the nitrite accumulation in supernatants
of HCF cultures incubated with or without ALA before
combination #1 treatment. Induced HCF showed 2.6
fold higher levels of nitrite in excess of control levels
(P < 0.05) (controls comprised normal HCF receiving no
pro-inflammatory combinations, or ALA treatment), while
in ALA-treated cultures, we observed 1.6 fold higher
levels (P > 0.05) of nitrite compared to controls. There was













































Fig. 1 The levels of nitrite accumulation in the medium of HCF induced by LPS at different concentrations with different combinations of
cytokines (Table 1) as measured by the Griess reaction. Measurements were performed at 24 h, 48 h and 72 h after applying the inflammatory
combinations. Each bar represents the mean and SD of media nitrite concentrations of triplicate cultures after 24, 48 and 72 h (n = 3). The asterisk
(P < 0.05) and double asterisk (P < 0.01) represent statistical significance for experiments vs medium alone
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in nitrite secretion in inflammatory-induced HCF cultures
treated with ALA as compared to HCF not treated with
ALA (Fig. 2).
Our preliminary results showed that PBMC released
high amounts of nitrite after treatment with LPS alone.
We have shown that in order to cause a significant pro-
duction of nitrite in HCF we need the combination of
cytokines.
Cultured human PBMCs were stimulated by LPS (LPS
B4) at a dose of 1000 ng/ml (n = 4). After 72 h, culture
medium was extracted, and nitrite levels were measured.
LPS concentration and incubation period were chosen
dependent on maximum nitrite secretion (data not
shown).
After incubating cultured human PBMC with and
without ALA, the cells were induced once again by LPS
at a dose of 100 ng/ml for a period of 72 h (n = 4). In
PBMCs stimulated by LPS after ALA treatment, nitrite
levels were reduced by 2.67 ± 0.519 folds compared to
4.95 ± 0.81 fold in PBMCs incubated in medium alone
(P > 0.05; Fig. 3).
Co-culturing PBMC with HCF that was induced by
LPS demonstrated similar results in nitrite level com-
pared to PBMC alone. In co-cultured cells induced by
LPS, nitrite accumulation was 4.2 ± 0.96 folds higher
compared to co-cultured cells incubated in medium
alone. Following ALA treatment, nitrite levels were re-
duced to 2.51 ± 0.78 folds compared to cells in medium
alone (P > 0.05; Fig. 4).
The effect of ALA on NOS-2 mRNA expression
Along with the investigation into the release of nitrite,
we evaluated the expression of NOS-2 in cells induced
by combination 1 treatment for 72 h (LPS B4 10 ng/ml
+ IL6 100 ng/ml + TNFα 100 ng/ml + IFN γ 100 ng/cc +
IL1β 100 ng/cc), which induced the highest nitrite secre-
tion, as compared to the other four combinations. Real-
time PCR confirmed that NOS-2 mRNA was induced in
cultures treated with LPS and pro-inflammatory cyto-
kines. Measurement of NOS-2 mRNA was made in cul-
tured HCF that were induced by combination # 1 with
(n = 4) and without (n = 4) incubation with ALA. Cultured
HCF induced by combination # 1 showed an increase in
NOS-2 mRNA expression compared to cells incubated in
medium alone (P < 0.001), and was normalized to 1. Treat-
ing inflammatory-induced HCF cultures with ALA in-
duced a 48.9 % decrease in NOS-2 mRNA expression
compared to inflammatory-induced HCF not treated with
ALA (P < 0.01) as measured by real-time PCR (Fig. 5).
Discussion
This study demonstrates that a combination of inflam-
matory cytokines has an recognizable effect on nitrite
secretion in HCF up to 48 h post-induction. Induction
with a combination of IL-6, LPS, TNF-α, IFN- γ and
IL-1β produced the highest nitrite secretion up to
72 h in vitro. Our data also demonstrates the production
of NOS-2 mRNA expression in HCF induced by the same































Nitrite Levels In HCF cells After ALA Treatment
Fig. 2 Nitrite accumulation in stimulated cultured HCF cells with and without incubation with ALA. HCF cells incubated with ALA for 2 h and
then exposed to 10 ng/ml LPS with cytokines, as described in combination 1. Nitrites were evaluated in supernatants after 72 h (n = 3). The asterisk
(P < 0.01) represents statistical significance (P < 0.01) for stimulated HCF cells stimulated after treatment with ALA vs stimulated HCF cells without ALA.
The double asterisk represents statistical significance (P < 0.01) for stimulated HCF cells vs HCF cells in medium alone. ALA - alpha-linoleic acid;
HCF - human conjunctival fibroblasts


























Nitrite Levels In Cultured PBMC 
After ALA Treatment
Fig. 3 Nitrite accumulation in LPS-induced peripheral blood mononuclear cells (PBMCs) with and without incubation with ALA. Cultured human
PBMCs were induced by LPS (LPS B4) at a dose of 1000 ng/ml. After 72 h, the culture medium was extracted and nitrite levels were measured
(n = 4). The asterisk (P < 0.01) represents statistical significance for PBMCs stimulated using LPS after treatment with ALA vs PBMCs stimulated
using LPS alone. Double asterisk (P < 0.001) represents statistical significance for PBMCs stimulated with LPS vs PBMC in medium alone.


























Nitrite Levels In Co-Cultured of PBMC 
and HCF Cells After ALA Treatment
Fig. 4 Nitrite accumulation in LPS-induced co-culture of peripheral blood mononuclear cells (PBMCs) and HCF cells with and without treatment
of ALA. Cultured human PBMC and HCF cells were induced by LPS (LPS B4) at a dose of 1000 ng/ml. After 72 h, the culture medium was extracted
and nitrite levels were measured (n = 4). The asterisk (P < 0.05) represents statistical significance for PBMCs stimulated using LPS after treatment with
ALA vs PBMC and HCF cells stimulated using LPS alone. Double asterisk (P < 0.001) represents statistical significance for PBMC stimulated with
LPS vs PBMC in medium alone. LPS - Lipopolysaccharide, ALA - alpha-linoleic acid; PBMC - peripheral blood mononuclear cells; HCF - human
conjunctival fibroblasts
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induction of NO. Our preliminary results showed that
PBMC released high amounts of nitrite after treatment
with LPS, unlike HCF. In order to cause a significant pro-
duction of nitrite in HCF, the cells need to be stimulated
with a combination of cytokines and LPS. Nitrite levels
were found to be significantly higher in LPS-induced
PBMCs as compared to induced cultured HCF. Treating
inflammatory-induced HCF and PBMC cultures with
ALA showed a significant decrease in nitrite levels, and
this impact was even larger on PBMC cultures.
In the first stage of our work, we induced an inflam-
matory reaction in HCF and HCE cells by using a com-
bination of cytokines and LPS. We did not use single
cytokines or LPS alone, due to earlier findings on animal
models showing that the combination of cytokines and
LPS up-regulate NOS-2 expression and cause an accu-
mulation of nitrite in significantly higher levels as com-
pared to treatment with a single cytokine or LPS alone
[36, 37]. In HCF cultures, our findings demonstrate that
all combinations of treatment cause a significant in-
crease in nitrite levels as soon as 24 h post-induction, as
noticed in earlier studies [37]. In agreement with previ-
ous studies [37], we did not find a significant elevation
in nitrite secretion by HCE cells when an inflammatory
reaction was induced.
We showed that IL-1β has an additional inductive ef-
fect when added to TNF-α, IFN- γ and LPS in both 48 h
and 72 h stimulation. This is opposed to a study by
Dighiero et al. [36] that showed no significant difference
in nitrite secretion in basal cell epithelioma and kerato-
cytes when adding IL-1β to, TNF-α, IFN- γ LPS.
In our study, the combination of IL-6, LPS, TNF-α,
IFN- γ and IL-1β that induced the highest nitrite secre-
tion, elicited 2.91-fold higher levels of nitrite after 72 h,
compared to cells incubated in medium alone. O’Brian et
al. [37] showed a similar effect on rabbit corneal stromal
cells using the same combination, without IL-6, to elicit 5-
fold higher levels of NO, compared to cells incubated in
medium alone. These results can be possible due to the
fact that it is known that different pro-inflammatory cyto-
kines, as well as LPS, have specific effects on different cell
types, and are species dependent [38].
Kim et al. [25] induced ocular inflammation in rabbits
in-vivo and showed that stromal fibroblasts and inflam-
matory cells are the main source of NO in ocular inflam-
mation. In addition, Kim et al. examined the levels of
NO in tears. According to the study, if the concentration
ratio of NO is 1.5-2.5 fold higher from the normal NO
functional level (the normal functional NO level was de-
fined as 1.0 in that study), NO may play a defensive role.
However, if the concentration ratio of NO is 3–10 folds
higher, NO may induce tissue damage. In our study,
HCF induce a relative low level of nitrite compared to
PBMCs. At these levels, NO may have a role in the nor-
mal healing process, or as a defense mechanism indu-
cing cell survival. On the other hand, PBMCs that
induce high levels of nitrite compared to HCF may take






















Inhibition Of NOS-2 mRNA Expression in HCF After ALA Treatment
Fig. 5 Inhibition of NOS-2 expression in inflammatory-induced HCF cells by Alpha-linoleic acid (ALA). Cultures of HCF cells were stimulated using
combination 1 (Table 1) for 72 h treatment and NOS-2 mRNA levels were measured using Real-time PCR (n = 4). Each bar represents the mean
SD of NOS-2 expression in quadruplicate cell cultures. The asterisk (P < 0.01) represents statistical significance for HCF cells stimulated using
combination 1 after ALA treatment vs HCF cells stimulated using combination 1. Double asterisk (P < 0.001) represents statistical significance for
HCF cells stimulated with combination 1 vs HCF cells in medium alone. LPS - Lipopolysaccharide, ALA - alpha-linoleic acid; HCF – human conjunctival
fibroblasts; NOS-2 - nitric oxide synthase 2
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oxidative stress, and DNA damage [25]. We may as-
sume, therefore that HCF, which are regularly exposed
to potential allergens and foreign substances, demon-
strate a constant protective effect on the ocular surface,
promoting quiescence and maintaining normal homeo-
stasis by secreting NO at low levels. Our findings regard-
ing the protective role of the conjunctiva match earlier
findings showing a nearly 100-fold increase in Interleukin
10 (IL-10) expression in ocular inflammation [9]. IL-10 in-
hibits both innate and T-cell–mediated immunity.
HCF secreted low levels of nitrite relative to PBMC. In
addition, co-culturing PBMCs with HCF induced by LPS
demonstrated similar results in nitrite levels compared
to PBMC alone. This finding indicates that PBMCs
could be the main source of NO release in inflammatory
events.
The ability of cells and tissues to regulate the produc-
tion and accumulation of NO in large amounts (accu-
mulations of 10 mM or greater), is by NOS-2, a 130 kDa
protein which is primarily regulated at the transcrip-
tional level. Our data documents the production of
NOS-2 mRNA expression, and nitrite accumulation in
cytokine/LPS-treated HCF cultured for 4 passages. The
elevated NOS-2 expression coincided in time with the
accumulation of nitrites. The ability to induce NOS-2 in
HCF required the presence of pro-inflammatory cyto-
kines and LPS. When comparing the nitrite accumula-
tion to the NOS-2 mRNA accumulation in HCF treated
with the same cytokine combination, there is a mis-
match between the significantly elevated NOS-2 expres-
sion compared to the relatively slight rise in nitrite levels
in medium culture. Vodovotz et al. [39] noted that
mouse peritoneal macrophages incubated with IFN- γ
and LPS, though initially producing NOS-2 protein and
NO, eventually, have a post-translational and non-
degradative inactivation of the enzyme. These cultured
cells with inactivated enzyme are somewhat comparable
with what was observed in HCF, expression of high
levels of NOS-2 mRNA, compared to low NO produc-
tion. This group also noted that the inactivation of
NOS-2 required the presence of LPS.
The role of NO in the pathogenesis of inflamma-
tory eye diseases is not well understood. In our work,
we indicate that PBMCs released a high concentra-
tion of nitrite relative to HCF. Our findings may cor-
roborate the results by Kim et al. that relatively low
NO concentration (released from HCF) during in-
flammation is probably part of normal wound heal-
ing, and serves as a defense mechanism inducing cell
survival [25].
The clinical data from studies on the systemic effects
of orally-administered n-3 PUFA, with the in-vivo mur-
ine study, demonstrate significant systemic and local
anti-inflammatory effects of n-3 PUFA [2–4].
Our results show that ALA, an n-3 PUFA, has a sig-
nificant inhibitory effect on the nitrite level secretion by
HCF, PBMC and co-culture of HCF and PBMC. These
findings can be explained by considering two earlier
studies: One by Xie et al. [40] which demonstrated that
NF-kappa B primarily regulates NO secretion through
iNOS gene expression [40], and the second was our pre-
vious study, which demonstrated that ALA decreased
NF-κB activity through Inhibitory factor-κBα (I-κBα)
mRNA expression in HCE cells [10].
In conclusion, in our study we have found evidence
that demonstrated that both nitrite levels and the ex-
pression of the mRNA of NOS decreased after ALA
treatment. The decrease in nitrite release and inhibition
of NOS-2 expression indicates that ALA may have an
anti-inflammatory effect both on HCF and on peripheral
immune cells. This knowledge brings us one-step for-
ward towards treatment of inflammation in ocular dis-
eases and decrease of the pathological mediators using
anti-inflammatory compounds such as ALA.
Competing interest
The authors declare that they have no competing interest.
Authors' contribution
NE designed the study, performed the experiments, wrote the manuscrip
and analysed data and statistics. NS designed the study, performed the
experiments, wrote the manuscrip and analysed data and statistics. EM
performed several experiments, participated in the design of the study and
analysed data and statistics. CY, HM and IA participated in the design of the
study and provided material and expertise. HO designed the study,
performed the experiments, analyzed the data and wrote the manuscript. AS
designed the study, performed the experiments, analyzed the data and
wrote the manuscript. All the experiments were performed in AS’s and HO’s
laboratories. All authors read and approved the final manuscript.
Acknowledgements
The authors would like to thank Devora Marks Ohana and Michelle Grunin
for critical reading of the manuscript.
Financial support
None of the authors have any proprietary or financial interest to disclose.
Grant support
This study was partially supported by Grant no. 7803 from the Chief Scientist
Office of the Ministry of Health, Israel.
Nir Erdinest is grateful to the Azrieli Foundation for the award of an Azrieli
Fellowship.
Author details
1Departments of Ophthalmology, Hadassah-Hebrew University Medical
Center, Jerusalem, Israel. 2Clinical Immunology and Allergy Unit,
Hadassah-Hebrew University Medical Center, Jerusalem, Israel. 3Department
of Neurology at The Agnes Ginges Center for Human Neurogenetics,
Hadassah-Hebrew University Medical Center, Jerusalem, Israel. 4Cornea and
Refractive Surgery Service, Department of Ophthalmology, Hadassah-Hebrew
University Medical Center, Jerusalem 91120, Israel.
Received: 20 August 2013 Accepted: 22 October 2015
References
1. Lewin GA, Schachter HM, Yuen D, Merchant P, Mamaladze V, Tsertsvadze A.
Effects of omega-3 fatty acids on child and maternal health. Evid Rep
Technol Assess. 2005;118:1–11.
Erdinest et al. Journal of Inflammation  (2015) 12:59 Page 8 of 9
2. Das UN. Essential fatty acids and their metabolites could function as
endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic,
anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and
cardioprotective molecules. Lipids Health Dis. 2008;7:37.
3. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential
fatty acids. Biomed Pharmacother. 2002;56(8):365–79.
4. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune
diseases. J Am Coll Nutr. 2002;21(6):495–505.
5. Dyerberg J, Bang HO. Haemostatic function and platelet polyunsaturated
fatty acids in Eskimos. Lancet. 1979;2(8140):433–5.
6. Leaf A, Weber PC. Cardiovascular effects of n-3 fatty acids. N Engl J Med.
1988;318(9):549–57.
7. Aragona P, Bucolo C, Spinella R, Giuffrida S, Ferreri G. Systemic omega-6
essential fatty acid treatment and pge1 tear content in Sjogren’s syndrome
patients. Invest Ophthalmol Vis Sci. 2005;46(12):4474–9.
8. Kokke KH, Morris JA, Lawrenson JG. Oral omega-6 essential fatty acid
treatment in contact lens associated dry eye. Cont Lens Anterior Eye.
2008;31(3):141–6.
9. Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR. Topical
omega-3 and omega-6 fatty acids for treatment of dry eye. Arch
Ophthalmol. 2008;126(2):219–25.
10. Erdinest N, Shmueli O, Grossman Y, Ovadia H, Solomon A. Anti-
inflammatory effects of alpha linolenic Acid on human corneal epithelial
cells. Invest Ophthalmol Vis Sci. 2012;53(8):4396–406.
11. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J.
1992;6(12):3051–64.
12. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology,
and pharmacology. Pharmacol Rev. 1991;43(2):109–42.
13. Brunet LR. Nitric oxide in parasitic infections. Int Immunopharmacol.
2001;1(8):1457–67.
14. van der Veen RC. Nitric oxide and T helper cell immunity. Int
Immunopharmacol. 2001;1(8):1491–500.
15. Bogdan C, Rollinghoff M, Diefenbach A. Reactive oxygen and reactive
nitrogen intermediates in innate and specific immunity. Curr Opin Immunol.
2000;12(1):64–76.
16. Er H, Turkoz Y, Ozerol IH, Uzmez E. Effect of nitric oxide synthase inhibition
in experimental Pseudomonas keratitis in rabbits. Eur J Ophthalmol.
1998;8(3):137–41.
17. Daheshia M, Kanangat S, Rouse BT. Production of key molecules by ocular
neutrophils early after herpetic infection of the cornea. Exp Eye Res.
1998;67(6):619–24.
18. Mandai M, Mittag TW, Kogishi J, Iwaki M, Hangai M, Yoshimura N. Role of
nitric oxide synthase isozymes in endotoxin-induced uveitis. Invest
Ophthalmol Vis Sci. 1996;37(5):826–32.
19. Sennlaub F, Courtois Y, Goureau O. Nitric oxide synthase-II is expressed in
severe corneal alkali burns and inhibits neovascularization. Invest
Ophthalmol Vis Sci. 1999;40(12):2773–9.
20. Yanagiya N, Akiba J, Kado M, Yoshida A, Kono T, Iwamoto J. Transient
corneal edema induced by nitric oxide synthase inhibition. Nitric Oxide.
1997;1(5):397–403.
21. Ko SM, Kim MK, Kim JC. The role of nitric oxide in experimental allergic
conjunctivitis. Cornea. 2000;19(1):84–91.
22. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell.
1994;78(6):915–8.
23. Yoshida M, Yoshimura N, Hangai M, Tanihara H, Honda Y. Interleukin-1
alpha, interleukin-1 beta, and tumor necrosis factor gene expression in
endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 1994;35(3):1107–13.
24. Arany I, Brysk MM, Brysk H, Tyring SK. Regulation of inducible nitric oxide
synthase mRNA levels by differentiation and cytokines in human
keratinocytes. Biochem Biophys Res Commun. 1996;220(3):618–22.
25. Kim JC, Park GS, Kim JK, Kim YM. The role of nitric oxide in ocular surface
cells. J Korean Med Sci. 2002;17(3):389–94.
26. Li DQ, Lokeshwar BL, Solomon A, Monroy D, Ji Z, Pflugfelder SC. Regulation
of MMP-9 production by human corneal epithelial cells. Exp Eye Res.
2001;73(4):449–59.
27. Jumblatt MM, Neufeld AH. Beta-adrenergic and serotonergic responsiveness
of rabbit corneal epithelial cells in culture. Invest Ophthalmol Vis Sci.
1983;24(8):1139–43.
28. Cunliffe IA, Richardson PS, Rees RC, Rennie IG. Effect of TNF, IL-1, and IL-6
on the proliferation of human Tenon’s capsule fibroblasts in tissue culture.
Br J Ophthalmol. 1995;79(6):590–5.
29. Weinberg JB, Haney AF. Spontaneous tumor cell killing by human blood
monocytes and human peritoneal macrophages: lack of alteration by endotoxin
or quenchers of reactive oxygen species. J Natl Cancer Inst. 1983;70(6):1005–10.
30. Weinberg JB, Muscato JJ, Niedel JE. Monocyte chemotactic peptide
receptor. Functional characteristics and ligand-induced regulation. J Clin
Invest. 1981;68(3):621–30.
31. Frieri M. Nitric oxide in allergic rhinitis and asthma. Allergy Asthma Proc.
1998;19(6):349–51.
32. De CR, Cybulsky MI, Clinton SK, Gimbrone Jr MA, Libby P. The omega-3 fatty
acid docosahexaenoate reduces cytokine-induced expression of
proatherogenic and proinflammatory proteins in human endothelial cells.
Arterioscler Thromb. 1994;14(11):1829–36.
33. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum
SR. Analysis of nitrate, nitrite, and [15 N]nitrate in biological fluids. Anal
Biochem. 1982;126(1):131–8.
34. Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative
RT-PCR. Genome Res. 1996;6(10):995–1001.
35. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR.
Genome Res. 1996;6(10):986–94.
36. Dighiero P, Behar-Cohen F, Courtois Y, Goureau O. Expression of inducible
nitric oxide synthase in bovine corneal endothelial cells and keratocytes in
vitro after lipopolysaccharide and cytokines stimulation. Invest Ophthalmol
Vis Sci. 1997;38(10):2045–52.
37. O'Brien WJ, Heimann T, Tsao LS, Seet BT, McFadden G, Taylor JL. Regulation
of nitric oxide synthase 2 in rabbit corneal cells. Invest Ophthalmol Vis Sci.
2001;42(3):713–9.
38. Kutty RK, Kutty G, Hooks JJ, Wiggert B, Nagineni CN. Transforming growth
factor-beta inhibits the cytokine-mediated expression of the inducible nitric
oxide synthase mRNA in human retinal pigment epithelial cells. Biochem
Biophys Res Commun. 1995;215(1):386–93.
39. Vodovotz Y, Kwon NS, Pospischil M, Manning J, Paik J, Nathan C.
Inactivation of nitric oxide synthase after prolonged incubation of mouse
macrophages with IFN-gamma and bacterial lipopolysaccharide. J Immunol.
1994;152(8):4110–8.
40. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa
B/Rel in induction of nitric oxide synthase. J Biol Chem. 1994;269(7):4705–8.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Erdinest et al. Journal of Inflammation  (2015) 12:59 Page 9 of 9
